Showing 7381-7390 of 20412 results for "".
Comparing First-Line TROP2-Directed ADCs in Metastatic TNBC: Latest Clinical Evidence
https://reachmd.com/programs/cme/comparing-first-line-trop2-directed-adcs-in-metastatic-tnbc-latest-clinical-evidence/60633/Explore how first-line TROP2-directed ADCs are reshaping metastatic TNBC care, with evidence-based treatment selection and proactive toxicity management.Can We Rely on Warm Weather to Stop the Spread of COVID-19?
https://reachmd.com/programs/covid-19-frontlines/can-we-rely-on-warm-weather-to-stop-the-spread-of-covid-19/11627/Conventional wisdom tells us that warm weather will slow the spread of contagion. But based on a recent report, that may not be the case with COVID-19.The Clinical Weight of TTR: What the Latest Data Reveal
https://reachmd.com/programs/cme/the-clinical-weight-of-ttr-what-the-latest-data-reveal/35934/Review emerging data on acoramidis and TTR levels in ATTR-CM, exploring associations with AFib, survival outcomes, biomarkers, and comorbidity burden.The HPV Data Is In — What Do the Newest Updates in Screening Mean For Your Patients?
https://reachmd.com/clinical-practice/obgyn-and-womens-health/the-hpv-data-is-in-what-do-the-newest-updates-in-screening-mean-for-your-patients/10075/This previously-aired broadcast provides a brief overview of the newest HPV screening recommendations and answers the audience’s pressing questions.Biomimicry
https://reachmd.com/ma-issues-index/july-august-2025/biomimicry-why-it-matters-for-dermal-fillers/36656/Why it matters for dermal fillersCDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian Cancer
https://reachmd.com/programs/cme/cdh6-in-focus-advancing-biomarker-driven-strategies-for-platinum-resistant-ovarian-cancer/36229/CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian CancerChairperson's Perspective: Novel Treatments for Newly Diagnosed Ph+ CML-CP: Striking the Balance of Treatment With Patient Goals and QoL
https://reachmd.com/programs/cme/chairpersons-perspective-novel-treatments-for-newly-diagnosed-ph-cml-cp-striking-the-balance-of-treatment-with-patient-goals-and-qol/28646/Join Dr. Jorge Cortes and learn about best practices for selecting optimal treatment plans for newly diagnosed Ph+ CML-CP.Building Bridges, Closing Gaps in NASH Care: The Pivotal Role of Gastroenterologists
https://reachmd.com/programs/cme/building-bridges-closing-gaps-in-nash-care-the-pivotal-role-of-gastroenterologists/15671/Are you up to date on the NAFLD clinical care pathway to provide optimal treatment for your patients?Harnessing the NAFLD/NASH Epidemic: Preparing for a New Treatment Paradigm
https://reachmd.com/programs/cme/harnessing-the-nafldnash-epidemic-preparing-for-a-new-treatment-paradigm/15673/Do you understand your role in determining which patient may benefit the most from NASH therapy?Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
https://reachmd.com/programs/cme/secondary-hyperparathyroidism-a-hidden-danger-in-chronic-kidney-disease/14973/How can you diagnose patients with SHPT earlier in CKD and control PTH levels early in the disease course? Our experts have what you need to know!